Valneva : Document AMF CP. 2023E887459

March 03, 2023 at 10:00 am EST

Date	Created	Title	Type	Company	Link
2023-03-03T00:00:00	2023-03-03T15:44:02.813	DeclarationPositionsCourtes	Document	VALNEVA SE	Link
2023-03-03T00:00:00	2023-03-03T15:44:01.72	DeclarationPositionsCourtes	Document	VERGNET SA	Link
2023-03-03T00:00:00	2023-03-03T15:42:05.877	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-03-03T00:00:00	2023-03-03T15:42:04.903	DeclarationPositionsCourtes	Document	CGG	Link
2023-03-03T00:00:00	2023-03-03T15:42:03.853	DeclarationPositionsCourtes	Document	EUROFINS SCIENTIFIC SE	Link
2023-03-03T00:00:00	2023-03-03T15:42:02.81	DeclarationPositionsCourtes	Document	BIOPHYTIS	Link
2023-03-03T00:00:00	2023-03-03T15:42:01.787	DeclarationPositionsCourtes	Document	EUTELSAT COMMUNICATIONS	Link
2023-03-03T00:00:00	2023-03-03T15:40:06.25	DeclarationPositionsCourtes	Document	VALEO	Link
2023-03-03T00:00:00	2023-03-03T15:40:05.197	DeclarationPositionsCourtes	Document	WORLDLINE	Link
2023-03-03T00:00:00	2023-03-03T15:40:04.16	DeclarationPositionsCourtes	Document	ELIS	Link
2023-03-03T00:00:00	2023-03-03T15:40:03.073	DeclarationPositionsCourtes	Document	CGG	Link
2023-03-03T00:00:00	2023-03-03T15:40:01.91	DeclarationPositionsCourtes	Document	UBISOFT ENTERTAINMENT	Link
2023-03-03T00:00:00	2023-03-03T15:38:08.53	DeclarationPositionsCourtes	Document	KORIAN	Link
2023-03-03T00:00:00	2023-03-03T15:38:07.447	DeclarationPositionsCourtes	Document	CASINO GUICHARD-PERRACHON	Link
2023-03-03T00:00:00	2023-03-03T13:48:01.877	Declarations	Document	PERNOD RICARD	Link
null	2023-03-03T12:01:36.38	DocumentOperation	Approbation	CREDIT AGRICOLE S.A.	Link
null	2023-03-03T12:01:33.473	Prospectus	Approbation	KLEPIERRE	Link
null	2023-03-03T12:00:31.903	DocumentEnregistrementUniversel	Depot	DBV TECHNOLOGIES	Link
null	2023-03-03T12:00:27.66	DocumentEnregistrementUniversel	Depot	L'AIR LIQUIDE	Link
2023-03-03T00:00:00	2023-03-03T12:00:21.227	Declarations	Document	CS GROUP	Link
2023-03-03T00:00:00	2023-03-03T12:00:18.547	Declarations	Document	ATOS SE	Link
2023-03-03T00:00:00	2023-03-03T12:00:15.75	Declarations	Document	ATOS SE	Link
2023-03-03T00:00:00	2023-03-03T12:00:01.463	DeclarationAchatVente	Document	OLYMPIQUE LYONNAIS GROUPE	Link
2023-03-03T00:00:00	2023-03-03T11:59:16.31	DeclarationAchatVente	Document	INTRASENSE	Link
2023-03-03T00:00:00	2023-03-03T11:59:15.307	DeclarationAchatVente	Document	CS GROUP	Link
null	2023-03-03T11:57:52.017	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:57:44.55	undefined	Communique	AMUNDI FINANCE EMISSIONS	Link
null	2023-03-03T11:57:37.267	undefined	Communique	AMUNDI FINANCE EMISSIONS	Link
null	2023-03-03T11:57:31.53	undefined	Communique	LCL EMISSIONS	Link
null	2023-03-03T11:57:25.467	undefined	Communique	LCL EMISSIONS	Link
null	2023-03-03T11:48:27.41	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:47:05.583	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:45:42.373	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:45:34.657	undefined	Communique	BPCE	Link
null	2023-03-03T11:36:48.923	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:26:56.1	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:18:08.213	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:09:11.513	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T11:00:25.773	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:51:27.217	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:42:39.877	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:33:52.483	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:25:00.123	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:16:02.09	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-03T10:06:03.767	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
2023-03-02T00:00:00	2023-03-02T18:10:01.733	DeclarationDirigeants	Document	ABIONYX PHARMA	Link
2023-03-02T00:00:00	2023-03-02T18:08:06.733	DeclarationDirigeants	Document	LEGRAND	Link
2023-03-02T00:00:00	2023-03-02T18:08:05.7	DeclarationDirigeants	Document	EDENRED	Link
2023-03-02T00:00:00	2023-03-02T18:08:04.69	DeclarationDirigeants	Document	GROUPE AIRWELL	Link
2023-03-02T00:00:00	2023-03-02T18:08:03.73	DeclarationDirigeants	Document	PREDILIFE	Link
2023-03-02T00:00:00	2023-03-02T18:08:02.793	DeclarationDirigeants	Document	GETLINK SE	Link
2023-03-02T00:00:00	2023-03-02T18:08:01.757	DeclarationDirigeants	Document	THERMADOR GROUPE	Link
2023-03-02T00:00:00	2023-03-02T18:06:06.07	DeclarationDirigeants	Document	ABIVAX	Link
2023-03-02T00:00:00	2023-03-02T18:06:05.107	DeclarationDirigeants	Document	SMART GOOD THINGS HOLDING S.A.	Link
2023-03-02T00:00:00	2023-03-02T18:06:04.11	DeclarationDirigeants	Document	BOUYGUES	Link
2023-03-02T00:00:00	2023-03-02T18:06:02.977	DeclarationDirigeants	Document	COMPAGNIE PLASTIC OMNIUM SE	Link
2023-03-02T00:00:00	2023-03-02T18:06:01.817	DeclarationDirigeants	Document	LEXIBOOK	Link
2023-03-02T00:00:00	2023-03-02T18:04:05.72	DeclarationDirigeants	Document	LVMH MOET HENNESSY-LOUIS VUITTON	Link
2023-03-02T00:00:00	2023-03-02T18:04:04.753	DeclarationDirigeants	Document	LVMH MOET HENNESSY-LOUIS VUITTON	Link
2023-03-02T00:00:00	2023-03-02T18:04:03.757	DeclarationDirigeants	Document	LVMH MOET HENNESSY-LOUIS VUITTON	Link
2023-03-02T00:00:00	2023-03-02T18:04:02.737	DeclarationDirigeants	Document	BIO-UV GROUP	Link
2023-03-02T00:00:00	2023-03-02T18:04:01.707	DeclarationDirigeants	Document	METADVERTISE	Link
2023-03-02T00:00:00	2023-03-02T16:34:01.753	Declarations	Document	HOPSCOTCH GROUPE	Link
2023-03-02T00:00:00	2023-03-02T16:28:01.8	Declarations	Document	CS GROUP	Link
2023-03-02T00:00:00	2023-03-02T15:38:02.867	DeclarationPositionsCourtes	Document	UBISOFT ENTERTAINMENT	Link
2023-03-02T00:00:00	2023-03-02T15:38:01.777	DeclarationPositionsCourtes	Document	VERGNET SA	Link
2023-03-02T00:00:00	2023-03-02T15:36:05.89	DeclarationPositionsCourtes	Document	EUROFINS SCIENTIFIC SE	Link
2023-03-02T00:00:00	2023-03-02T15:36:04.86	DeclarationPositionsCourtes	Document	FAURECIA	Link
2023-03-02T00:00:00	2023-03-02T15:36:02.777	DeclarationPositionsCourtes	Document	TELEPERFORMANCE	Link
2023-03-02T00:00:00	2023-03-02T15:34:05.223	DeclarationPositionsCourtes	Document	EUROFINS SCIENTIFIC SE	Link
2023-03-02T00:00:00	2023-03-02T15:34:04.173	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-03-02T00:00:00	2023-03-02T15:34:03.123	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-03-02T00:00:00	2023-03-02T15:34:01.703	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-03-02T00:00:00	2023-03-02T14:36:03.23	Declarations	Document	NICOX SA	Link
null	2023-03-02T14:22:01.807	NotesEtAutresInformations	Depot	CS GROUP	Link
2023-03-02T00:00:00	2023-03-02T13:30:01.94	Declarations	Document	UBISOFT ENTERTAINMENT	Link
2023-03-02T00:00:00	2023-03-02T13:28:01.807	DeclarationAchatVente	Document	OLYMPIQUE LYONNAIS GROUPE	Link
2023-03-02T00:00:00	2023-03-02T13:26:01.747	DeclarationAchatVente	Document	INTRASENSE	Link
2023-03-02T00:00:00	2023-03-02T13:22:01.83	DeclarationAchatVente	Document	CS GROUP	Link
null	2023-03-02T11:53:14.347	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:44:27.207	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:35:41.477	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:34:19.01	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:32:56.783	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:32:12.45	undefined	Communique	CREDIT SUISSE AG, LONDON BRANCH	Link
null	2023-03-02T11:30:50.637	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:29:27.477	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:29:21.8	undefined	Communique	LCL EMISSIONS	Link
null	2023-03-02T11:20:33.483	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:19:12.233	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:10:21.937	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T11:01:34.307	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:52:40.613	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:43:51.653	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:34:55.29	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:25:57.793	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:17:02.967	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:07:48.027	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-03-02T10:07:31.483	undefined	Communique	CREDIT SUISSE AG, LONDON BRANCH	Link
null	2023-03-02T10:04:16.233	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link

Attachments

Original Link
Original Document
Permalink

Disclaimer

Valneva SE published this content on 03 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 March 2023 14:59:07 UTC.

	1st Jan change	Capi.
VALNEVA	-26.99%	512M
IQVIA HOLDINGS INC.	+1.12%	42.59B
MODERNA, INC.	+6.77%	40.65B
LONZA GROUP AG	+45.26%	40.57B
CELLTRION, INC.	-11.96%	26.77B
ICON PUBLIC LIMITED COMPANY	+6.01%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-24.92%	18.17B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.63%	11.7B
MEDPACE HOLDINGS, INC.	+27.16%	12.05B
UNITED THERAPEUTICS CORPORATION	+7.30%	11.1B

1st Jan change

Capi.

VALNEVA

-26.99%

512M

IQVIA HOLDINGS INC.

+1.12%

42.59B

MODERNA, INC.

+6.77%

40.65B

LONZA GROUP AG

+45.26%

40.57B

CELLTRION, INC.

-11.96%

26.77B

ICON PUBLIC LIMITED COMPANY

+6.01%

24.81B

ALNYLAM PHARMACEUTICALS, INC.

-24.92%

18.17B

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

-3.63%

11.7B

MEDPACE HOLDINGS, INC.

+27.16%

12.05B

UNITED THERAPEUTICS CORPORATION

+7.30%

11.1B

Market Closed - Euronext Paris Other stock markets 11:35:16 2024-04-25 am EDT			5-day change	1st Jan Change
3.446 ^EUR	-3.96%		-6.86%	-26.99%

Apr. 11	Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	CF
Mar. 26	Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	MT

Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	Apr. 11	CF
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	Mar. 26	MT
Valneva: Phase 1 trial initiated in the Zika virus	Mar. 26	CF
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	Mar. 26	CI
ADRs End Higher; XTL Biopharmaceuticals Climbs 129%	Mar. 20	DJ
Valneva SE Raises Revenue Guidance for 2024	Mar. 20	CI
Valneva SE Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Transcript : Valneva SE, 2023 Earnings Call, Mar 20, 2024	Mar. 20
Valneva: share price down, forecasts below expectations	Mar. 20	CF
French biotech company Valneva raises product sales guidance	Mar. 20	RE
Valneva: first loan repayment postponed	Mar. 18	CF
Valneva Secures 18-month Extension to Interest-only Period for US Debt Facility	Mar. 18	MT
Valneva: the Grimaud family group below 15% of voting rights	Mar. 05	CF
U.S. CDC Advisory Committee Recommends Use of Valneva?s Single-Dose Chikungunya Vaccine IXCHIQ	Feb. 29	CI
Valneva: Ixchiq vaccine recommended by ACIP	Feb. 29	CF
US Centers for Disease Control's Committee Recommends Valneva's Chikungunya Virus Vaccine	Feb. 29	MT
Valneva SE Announces Revenue Results for Full Year 2023	Feb. 15	CI
Valneva Se Announces Earnings Guidance for 2024	Feb. 15	CI
Valneva: 26% increase in product sales in 2023	Feb. 15	CF
VALNEVA : Oddo BHF confirms its recommendation on the stock	Feb. 05	CF
Valneva Sells Tropical Disease Priority Review Voucher for $103 Million	Feb. 05	MT
Valneva Sells Chikungunya Virus Vaccine’s Priority Review Voucher for $103 Million	Feb. 05	MT
Valneva: sale of priority review warrant for Ixchiq	Feb. 05	CF
Valneva: Grimaud holds less than 10% of the capital	Jan. 15	CF
Valneva Se Announces the First Participant Has Been Vaccinated in the Phase 2 Clinical Trial Evaluating the Safety and Immunogenicity in Children of Two Different Dose Levels of Valneva?S Single-Shot Chikungunya Vaccine	Jan. 10	CI

Valneva

Equities

VLA

FR0004056851

Biotechnology & Medical Research

Valneva : Document AMF CP. 2023E887459

Latest news about Valneva

Chart Valneva

Company Profile

Income Statement Evolution

Ratings for Valneva

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research